LionBird

LionBird is a venture capital firm founded in 2012, with offices in Tel Aviv, Israel, and Evanston, Illinois. It specializes in early-stage investments in software companies, particularly within the healthcare, commerce, and enterprise sectors. The firm focuses on innovative digital businesses that utilize online technology to transform traditional offline processes and models. Its investment strategy encompasses a range of areas, including cloud computing, financial technology, and digital solutions aimed at enhancing various industries. LionBird typically invests between $0.2 million and $0.75 million in each company, emphasizing disruptive and transformative startups that have the potential to make a significant impact in their respective markets.

Edward Michael

Managing Partner

Gal Noyman Veksler

Principal

63 past transactions

Phantom Neuro

Series A in 2025
Phantom Neuro is a neurotechnology company focused on developing innovative muscle-machine interfaces to enhance robotic limb rehabilitation. By integrating neurotechnology with robotic systems, Phantom Neuro aims to improve mobility for users through precise control of robotic limbs, facilitating more natural movement and enhancing user experiences. The company employs a minimally invasive approach, which allows for effective rehabilitation solutions that address the needs of individuals with mobility challenges. Additionally, Phantom Neuro explores various applications of its technologies within the broader field of assistive robotics, striving to provide valuable tools that help patients with limb deficits regain control over their lives and improve their overall quality of life.

Jimini Health

Pre Seed Round in 2024
Jimini Health is a mental health company dedicated to enhancing the effectiveness of mental health care globally. Established in 2023 by a team of experienced professionals in AI, biotech, and psychology, Jimini combines teletherapy with personalized AI support to create a comprehensive care model. Patients receive assistance from licensed clinicians and an AI therapy assistant named Sage, who work collaboratively to help individuals achieve their mental health goals. Jimini emphasizes the importance of clinical oversight and safety, ensuring that its technology is purpose-built and rooted in scientific principles. The company focuses on evidence-based practices and individualized care, particularly for those experiencing persistent anxiety. By integrating advanced technology with expert clinical guidance, Jimini aims to deliver high-quality mental health experiences that empower patients to take proactive steps in their treatment.

OneStep

Series B in 2024
OneStep is a digital health platform based in Tel Aviv, Israel, that offers clinically validated feedback to clients. The company specializes in providing digital physical therapy services, focusing on measurable outcomes through the analysis of patients' movements. By utilizing a smartphone application equipped with motion intelligence, OneStep enables physical therapists and personal care teams to create tailored recovery plans. Patients can track their progress and receive actionable real-time feedback, which enhances their rehabilitation experience and supports their recovery journey.

PatientPartner

Seed Round in 2024
PatientPartner is a digital health platform that aims to enhance the patient experience by connecting individuals facing similar health challenges with a network of physicians and supportive peers. By integrating real-world experiences, the platform educates patients and guides them through their treatment journeys, fostering informed medical decision-making. Utilizing artificial intelligence and machine learning, PatientPartner facilitates meaningful interactions between patients, healthcare providers, and industry partners, creating a comprehensive resource for healthcare needs. The company collaborates with physicians, healthcare institutions, and medical technology firms to attract engaged patients, minimize drop-off rates, and gather valuable long-term outcome data, all with the goal of improving patient care and experiences.

Heyday Health

Venture Round in 2024
Heyday Health is a provider of hybrid primary healthcare services focused on delivering personalized medical care to adults. The company offers a combination of in-home and virtual visits, allowing patients to access healthcare conveniently and efficiently. With a clinical team that includes physicians, nurse practitioners, and health allies, Heyday Health ensures continuous accessibility to care, including same-day appointments and round-the-clock support. This approach is designed to enhance the quality of life for seniors by making healthcare more accessible and tailored to individual needs.

Black Ore Technologies

Seed Round in 2023
Black Ore Technologies is an AI-driven financial services company. It develops and creates an AI product called Tax Autopilot, that offers end-to-end 1040 tax prep automation for CPAs and tax firms. Black Ore Technologies was founded in 2022 and is based in Texas, USA.

PhaseV

Seed Round in 2023
PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution, enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner.

Mana.bio

Seed Round in 2023
Mana.bio is an AI-based drug delivery startup that specializes in gene therapy, focusing on both DNA and RNA-based therapeutics as well as vaccines. The company utilizes advanced technology that combines machine learning with nanotechnology to enhance the development of lipid nanoparticle systems, which are crucial for oligonucleotide therapies. By identifying optimal formulations for these delivery systems, Mana.bio aims to improve drug delivery services in the healthcare industry, thereby facilitating more effective therapeutic solutions.

Chiefy

Seed Round in 2023
Chiefy is a healthcare company based in New York that focuses on enhancing surgical safety and efficiency through a collaborative platform designed for perioperative teams. Founded in 2020 by Maya Ber Lerner and Assaf Ziv, Chiefy's platform facilitates asynchronous virtual huddles that allow surgeons, anesthesiologists, nurses, and other stakeholders to align on case plans prior to surgery. By capturing lessons, notes, and feedback post-procedure, Chiefy promotes continuous improvement and streamlined communication among medical teams. This approach not only automates administrative tasks but also integrates quality and best communication practices into daily operations, ultimately improving patient care and fostering smarter collaboration within surgical environments.

Nest Genomics (YC W22)

Seed Round in 2023
Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.

Theranica

Series C in 2022
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.

Rhino Federated Computing

Venture Round in 2022
The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.

FundGuard

Series B in 2022
FundGuard Inc. is a technology company that specializes in developing an artificial intelligence-powered, cloud-based platform for investment management and administration. The FundGuard platform is designed to assist asset and fund managers in overseeing investments across various categories, including mutual funds, ETFs, hedge funds, insurance, and pension funds. Utilizing advanced AI and cloud technology, the platform automatically detects financial anomalies, resolves exceptions, and offers recommendations to enhance operational performance. By providing real-time transparency, FundGuard enables asset managers and fund administrators to transform their product offerings into more efficient digital experiences. Founded in 2018, the company is headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel.

Phantom Neuro

Seed Round in 2022
Phantom Neuro is a neurotechnology company focused on developing innovative muscle-machine interfaces to enhance robotic limb rehabilitation. By integrating neurotechnology with robotic systems, Phantom Neuro aims to improve mobility for users through precise control of robotic limbs, facilitating more natural movement and enhancing user experiences. The company employs a minimally invasive approach, which allows for effective rehabilitation solutions that address the needs of individuals with mobility challenges. Additionally, Phantom Neuro explores various applications of its technologies within the broader field of assistive robotics, striving to provide valuable tools that help patients with limb deficits regain control over their lives and improve their overall quality of life.

Maverick Medical AI

Seed Round in 2022
Maverick Medical AI discovers & unlock the full value of risk adjustment to help achieve financial success.

Phrase Health

Seed Round in 2021
Phrase Health help hospitals monitor and analyze the information they provide to doctors and nurses at the point of care.

Assured Allies

Series A in 2021
Assured Allies is focused on addressing the financial challenges families face due to aging through its longevity assurance platform. This platform employs predictive algorithms and preventive medical interventions to create individualized aging plans that include psychosocial assessments and recommended support services. By collaborating with leaders in the long-term care industry and insurance companies, Assured Allies aims to enhance the support provided to policyholders as they navigate the complexities of aging. The company’s continuous ally support further ensures that individuals receive the necessary assistance throughout their later years.

Protenus

Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Laguna Health

Seed Round in 2021
Laguna Health offers AI-powered contextual care management services designed to enhance personalized healthcare, particularly during hospital transitions. By leveraging advanced natural language processing and AI technology, Laguna Health provides care managers with a tool that improves efficiency and consistency in responding to individual patient needs. The company's solution integrates seamlessly with existing platforms and workflows, eliminating the need for additional integration. Supported by published clinical research and partnerships with national health plans, Laguna Health demonstrates its effectiveness in driving cost savings and productivity gains for care managers. This approach ultimately helps employers and integrated delivery networks improve health outcomes for their members while streamlining care management processes.

Nimble Beauty

Seed Round in 2021
Nimble Beauty, founded in 2016 by Avichay Mor-Yosef and Omri Moran, is based in Brooklyn, New York. The company specializes in developing an innovative machine that automates the manicure process using advanced 3D image processing technologies. This device is designed to deliver salon-quality nail polish application in the comfort of one's home. It features a unique mounting element that includes a capsule compartment for storing nail polishes and allows fingers to be inserted for effortless application. Nimble Beauty aims to simplify the nail care experience, making professional-quality results accessible to consumers without the need for traditional salon visits.

C2i Genomics

Series B in 2021
C2i Genomics, Inc. specializes in whole genome analysis solutions aimed at monitoring tumor recurrence in post-surgery cancer patients. The company offers liquid biopsy services that analyze subtle changes in tumor DNA to provide insights into cancer progression and recurrence. This technology enables the development of a bio-platform approach applicable across various cancer types, facilitating the guidance of diverse treatment modalities, including surgery, chemotherapy, immunotherapy, and targeted therapies. Additionally, C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations, enhancing the ability of healthcare providers to monitor treatment responses and detect recurrences or failures earlier than traditional methods allow. Founded in 2019 and headquartered in New York, with a research and development center in Haifa, Israel, C2i Genomics aims to improve the lives and outcomes of cancer patients through innovative diagnostic solutions.

FundGuard

Series A in 2021
FundGuard Inc. is a technology company that specializes in developing an artificial intelligence-powered, cloud-based platform for investment management and administration. The FundGuard platform is designed to assist asset and fund managers in overseeing investments across various categories, including mutual funds, ETFs, hedge funds, insurance, and pension funds. Utilizing advanced AI and cloud technology, the platform automatically detects financial anomalies, resolves exceptions, and offers recommendations to enhance operational performance. By providing real-time transparency, FundGuard enables asset managers and fund administrators to transform their product offerings into more efficient digital experiences. Founded in 2018, the company is headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel.

Rhino Federated Computing

Seed Round in 2021
The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.

Remesh

Series A in 2020
Remesh offers an AI-powered platform that enables users to have live conversations with their customers at scale and organize audience responses in real-time. It helps users to understand their customers or employees and make more informed business decisions by empowering them to engage with up to 1,000 people at once- online and in real-time.

FlipOS

Venture Round in 2020
FlipOS is a b2b Decentralized iBuyer, tailor made for professionals. Stoa partners with real estate investors who buy, renovate and sell single family homes. We fund their deals, create the renovation scope and purchase the properties from them at the end of the renovation. Our proprietary technology allows us to significantly shorten the process without compromising the quality of service.

Protenus

Series C in 2019
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

metaMe Health

Seed Round in 2019
MetaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.

Theranica

Series B in 2019
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.

FundGuard

Seed Round in 2018
FundGuard Inc. is a technology company that specializes in developing an artificial intelligence-powered, cloud-based platform for investment management and administration. The FundGuard platform is designed to assist asset and fund managers in overseeing investments across various categories, including mutual funds, ETFs, hedge funds, insurance, and pension funds. Utilizing advanced AI and cloud technology, the platform automatically detects financial anomalies, resolves exceptions, and offers recommendations to enhance operational performance. By providing real-time transparency, FundGuard enables asset managers and fund administrators to transform their product offerings into more efficient digital experiences. Founded in 2018, the company is headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel.

Assured Allies

Seed Round in 2018
Assured Allies is focused on addressing the financial challenges families face due to aging through its longevity assurance platform. This platform employs predictive algorithms and preventive medical interventions to create individualized aging plans that include psychosocial assessments and recommended support services. By collaborating with leaders in the long-term care industry and insurance companies, Assured Allies aims to enhance the support provided to policyholders as they navigate the complexities of aging. The company’s continuous ally support further ensures that individuals receive the necessary assistance throughout their later years.

Remesh

Series A in 2018
Remesh offers an AI-powered platform that enables users to have live conversations with their customers at scale and organize audience responses in real-time. It helps users to understand their customers or employees and make more informed business decisions by empowering them to engage with up to 1,000 people at once- online and in real-time.

TytoCare

Series C in 2018
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Protenus

Series B in 2018
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

PhysIQ

Series B in 2017
PhysIQ, Inc. is a health technology company based in Chicago, Illinois, that specializes in a cloud-based predictive platform for personalized physiology analytics. The company has developed a platform that analyzes multiple data streams to establish individual baseline norms for patients, allowing clinicians to monitor vital signs and detect clinically significant changes. This innovative approach helps manage chronic illnesses by predicting acute medical events before symptoms arise and empowers consumers to take control of their health and fitness. PhysIQ's solution is applicable in both regulated healthcare and unregulated health and fitness markets, and it can be integrated into other patient monitoring devices, enhancing their capabilities. Founded in 2013, PhysIQ was previously known as VGBio, Inc.

Protenus

Series A in 2017
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Theranica

Series A in 2017
Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.

Remesh

Seed Round in 2017
Remesh offers an AI-powered platform that enables users to have live conversations with their customers at scale and organize audience responses in real-time. It helps users to understand their customers or employees and make more informed business decisions by empowering them to engage with up to 1,000 people at once- online and in real-time.

Bizzabo

Series B in 2017
Bizzabo Ltd. is a cloud-based event management platform that offers a comprehensive suite of tools for creating and managing in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company provides services such as registration and ticketing, event marketing, website building, agenda management, networking apps, and sponsorship opportunities. Bizzabo's platform is designed to enhance attendee engagement and facilitate effective event execution, allowing organizations to achieve meaningful business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, and associations, and has a global workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, and London, as well as remote locations worldwide. Bizzabo has gained recognition as a leader in the event management space, trusted by major brands to power their event experiences.

Lawgeex

Series A in 2017
LawGeex is transforming legal. For companies who want to spend less time on contracts and focus on high-impact work, LawGeex automates the review and approval of everyday contracts with unparalleled accuracy, consistency, and scalability through our advanced AI platform. LawGeex is recognized by Gartner, Wired magazine, and CB Insights as a leading force in bringing innovation and technology to the legal world – and is trusted by global firms such as eBay, Bain & Company, and White & Case.

Lawgeex

Series A in 2016
LawGeex is transforming legal. For companies who want to spend less time on contracts and focus on high-impact work, LawGeex automates the review and approval of everyday contracts with unparalleled accuracy, consistency, and scalability through our advanced AI platform. LawGeex is recognized by Gartner, Wired magazine, and CB Insights as a leading force in bringing innovation and technology to the legal world – and is trusted by global firms such as eBay, Bain & Company, and White & Case.

Ovia Health

Venture Round in 2016
Ovia Health offers a comprehensive maternity and family benefits solution that transforms the way women and families are supported throughout the parenthood journey. The company is formerly known as Ovuline is making healthcare a lifestyle. Its mobile apps, Ovia Fertility and Ovia Pregnancy, have helped millions of women start their families and live healthier lives.

Bluesight

Series C in 2016
Bluesight addresses supply chain inefficiencies in healthcare by offering actionable analytics throughout the medication lifecycle. The company has developed a hospital inventory management platform that automates pharmacy kit processing and medication tracking, aiming to streamline the often cumbersome and error-prone manual processes associated with medication handling. By implementing automation technology, Bluesight enhances operational efficiency, improves patient safety, and increases medication visibility within hospitals. Through its suite of Medication Intelligence solutions, the company simplifies the complexities of medication management, providing healthcare professionals with the tools needed for better decision-making and risk reduction.

Bento for Business

Series A in 2016
Bento for Business is a financial operating platform designed specifically for small and mid-sized businesses (SMBs). The platform enables businesses to issue payment credentials securely, offering virtual and corporate cards along with comprehensive management tools that enhance control and visibility over company expenses. By minimizing fraud and reducing administrative overhead, Bento's solutions allow businesses to streamline their financial processes, freeing them to concentrate on growth and customer value. The company also provides open APIs and white label partnerships, extending its capabilities to automate payments beyond employee expenses. With its headquarters in San Francisco and Chicago, Bento is recognized for its innovative approach to expense management, combining the security of traditional banking with the user-friendly features typical of modern technology firms.

Sweetch

Series A in 2016
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions aimed at improving clinical outcomes for individuals with chronic conditions. The company's hyper-personalized engagement platform offers tailored recommendations that consider the appropriate timing, tone, and real-world context for each patient's health journey. This approach enables pharmaceutical companies, medical device manufacturers, payers, and healthcare providers to foster continuous relationships and effectively engage with patients at scale, ultimately supporting individuals in achieving their health goals.

Protenus

Series A in 2016
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Staffly

Seed Round in 2015
Staffly, Inc. is a staffing company based in San Francisco, California, that specializes in connecting retailers with both temporary and direct-hire employees. Founded in 2014, the company offers an online retail staffing application that streamlines the process of recruiting part-time workers. Staffly manages various aspects of the hiring process, including interviewing, background checks, training, and payroll, while also ensuring compliance with local, state, and federal regulations. The platform facilitates efficient communication between retailers and prospective employees, allowing for on-demand recruitment through mobile devices. This service is particularly valuable for retailers facing issues with absenteeism and employee turnover.

Lawgeex

Seed Round in 2015
LawGeex is transforming legal. For companies who want to spend less time on contracts and focus on high-impact work, LawGeex automates the review and approval of everyday contracts with unparalleled accuracy, consistency, and scalability through our advanced AI platform. LawGeex is recognized by Gartner, Wired magazine, and CB Insights as a leading force in bringing innovation and technology to the legal world – and is trusted by global firms such as eBay, Bain & Company, and White & Case.

TytoCare

Series B in 2015
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Bizzabo

Convertible Note in 2015
Bizzabo Ltd. is a cloud-based event management platform that offers a comprehensive suite of tools for creating and managing in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company provides services such as registration and ticketing, event marketing, website building, agenda management, networking apps, and sponsorship opportunities. Bizzabo's platform is designed to enhance attendee engagement and facilitate effective event execution, allowing organizations to achieve meaningful business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, and associations, and has a global workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, and London, as well as remote locations worldwide. Bizzabo has gained recognition as a leader in the event management space, trusted by major brands to power their event experiences.

Genome Compiler

Seed Round in 2015
Genome Compiler is a computer aided design and collaboration platforms for the synthetic biology industry. Genome Compiler Corporation provides an integrated intuitive software platform for rapid engineering of biology with its genomic manipulation tools and its optimal design experience. The Genome Compiler CAD tool allows scientists in the biotechnology, agriculture and pharmaceutical industries to design, debug and compile biological code, to develop better bio-based products faster. We strive to make the programming of living things easy and accessible.

Fundbox

Series B in 2015
Fundbox is an AI-powered financial platform based in San Francisco, established in 2013 by co-founders Eyal Shinar, Tomer Michaeli, and Yuval Ariav. The company provides small businesses with quick and intuitive access to credit, aiming to enhance customer growth within the small business economy. Fundbox utilizes machine learning and deep data analytics to offer invoice financing and lines of credit, allowing small and mid-sized enterprises to efficiently accelerate cash flow against outstanding invoices. This approach not only improves payment terms but also helps increase average order volumes and close rates for its clients.

Bento for Business

Seed Round in 2015
Bento for Business is a financial operating platform designed specifically for small and mid-sized businesses (SMBs). The platform enables businesses to issue payment credentials securely, offering virtual and corporate cards along with comprehensive management tools that enhance control and visibility over company expenses. By minimizing fraud and reducing administrative overhead, Bento's solutions allow businesses to streamline their financial processes, freeing them to concentrate on growth and customer value. The company also provides open APIs and white label partnerships, extending its capabilities to automate payments beyond employee expenses. With its headquarters in San Francisco and Chicago, Bento is recognized for its innovative approach to expense management, combining the security of traditional banking with the user-friendly features typical of modern technology firms.

Bluesight

Series B in 2015
Bluesight addresses supply chain inefficiencies in healthcare by offering actionable analytics throughout the medication lifecycle. The company has developed a hospital inventory management platform that automates pharmacy kit processing and medication tracking, aiming to streamline the often cumbersome and error-prone manual processes associated with medication handling. By implementing automation technology, Bluesight enhances operational efficiency, improves patient safety, and increases medication visibility within hospitals. Through its suite of Medication Intelligence solutions, the company simplifies the complexities of medication management, providing healthcare professionals with the tools needed for better decision-making and risk reduction.

PhysIQ

Series A in 2014
PhysIQ, Inc. is a health technology company based in Chicago, Illinois, that specializes in a cloud-based predictive platform for personalized physiology analytics. The company has developed a platform that analyzes multiple data streams to establish individual baseline norms for patients, allowing clinicians to monitor vital signs and detect clinically significant changes. This innovative approach helps manage chronic illnesses by predicting acute medical events before symptoms arise and empowers consumers to take control of their health and fitness. PhysIQ's solution is applicable in both regulated healthcare and unregulated health and fitness markets, and it can be integrated into other patient monitoring devices, enhancing their capabilities. Founded in 2013, PhysIQ was previously known as VGBio, Inc.

amSTATZ

Seed Round in 2014
amSTATZ is a cloud based software for fitness professionals and studios who want to save time, stay organized and grow client relationships. Unlike traditional fitness business software, amSTATZ streamlines your operations, from a simplified booking & payment process to the workout homework you assign to clients between sessions.

Fundbox

Series A in 2014
Fundbox is an AI-powered financial platform based in San Francisco, established in 2013 by co-founders Eyal Shinar, Tomer Michaeli, and Yuval Ariav. The company provides small businesses with quick and intuitive access to credit, aiming to enhance customer growth within the small business economy. Fundbox utilizes machine learning and deep data analytics to offer invoice financing and lines of credit, allowing small and mid-sized enterprises to efficiently accelerate cash flow against outstanding invoices. This approach not only improves payment terms but also helps increase average order volumes and close rates for its clients.

TytoCare

Series A in 2014
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Ovia Health

Seed Round in 2013
Ovia Health offers a comprehensive maternity and family benefits solution that transforms the way women and families are supported throughout the parenthood journey. The company is formerly known as Ovuline is making healthcare a lifestyle. Its mobile apps, Ovia Fertility and Ovia Pregnancy, have helped millions of women start their families and live healthier lives.

Bluesight

Series A in 2013
Bluesight addresses supply chain inefficiencies in healthcare by offering actionable analytics throughout the medication lifecycle. The company has developed a hospital inventory management platform that automates pharmacy kit processing and medication tracking, aiming to streamline the often cumbersome and error-prone manual processes associated with medication handling. By implementing automation technology, Bluesight enhances operational efficiency, improves patient safety, and increases medication visibility within hospitals. Through its suite of Medication Intelligence solutions, the company simplifies the complexities of medication management, providing healthcare professionals with the tools needed for better decision-making and risk reduction.

Ovia Health

Seed Round in 2013
Ovia Health offers a comprehensive maternity and family benefits solution that transforms the way women and families are supported throughout the parenthood journey. The company is formerly known as Ovuline is making healthcare a lifestyle. Its mobile apps, Ovia Fertility and Ovia Pregnancy, have helped millions of women start their families and live healthier lives.

CartCrunch

Seed Round in 2012
CartCrunch is a shopping list application designed to help grocery shoppers save time and money. Users can create shopping lists manually or scan their grocery receipts, which allows the app to automatically populate the list with items and their corresponding prices. CartCrunch enhances the shopping experience by finding the best local supermarkets for users, offering personalized local coupons and promotions based on their shopping habits and previous receipts. By utilizing crowd-sourced data to update prices and discounts, CartCrunch empowers consumers to make informed purchasing decisions and maximize their savings while grocery shopping.

streamOnce

Seed Round in 2012
StreamOnce transforms how teams collaborate by connecting today’s business systems into their social enterprise system. By bringing all of the relevant information for different systems to one social place, your team can search, manage and respond instantly to information.

ShopClues

Series A in 2012
ShopClues is India's first and the largest managed marketplace with more than 100 million monthly visitors on its website. Founded in July 2011 in Silicon Valley, with 2.5cr listed products and over 6,00,000 + merchants, ShopClues aims to provide the best online shopping experience to its customers - starting from the great selection, low price, ease of use, fast delivery, and ending with the best customer service you have ever experienced. ShopClues ships in over 25k cities across India and has thousands of online stores. The company is run by an energetic team of over 1100+ people and is funded by leading institutional investors, is an Indian subsidiary of Clues Network Inc., a US Corporation and is based out of Gurgaon.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.